KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 126 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $29,797,000 | +12.0% | 395,660 | -25.4% | 0.40% | +25.5% |
Q1 2015 | $26,611,000 | +44.1% | 530,635 | -0.3% | 0.32% | +49.8% |
Q4 2014 | $18,465,000 | +0.8% | 532,445 | -4.8% | 0.22% | +2.4% |
Q3 2014 | $18,315,000 | +461.1% | 559,075 | +557.3% | 0.21% | +500.0% |
Q2 2014 | $3,264,000 | – | 85,055 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 1,382,722 | $69,344,000 | 3.43% |
Versant Venture Management, LLC | 70,376 | $3,529,356,000 | 3.10% |
AlpInvest Partners B.V. | 29,731 | $1,491,000 | 2.79% |
Partner Investment Management, L.P. | 29,178 | $1,463,000 | 2.20% |
PFM Health Sciences, LP | 1,242,509 | $62,312,000 | 1.72% |
Aureus Asset Management, LLC | 130,307 | $6,535,000 | 1.50% |
BRIDGER MANAGEMENT, LLC | 444,999 | $22,317,000 | 1.49% |
HealthCor Management, L.P. | 425,000 | $21,314,000 | 1.02% |
Redmile Group, LLC | 225,062 | $11,287,000 | 1.01% |
REGENTATLANTIC CAPITAL LLC | 174,454 | $8,749,000 | 0.77% |